Annual CFI
-$129.39 M
-$134.71 M-2530.73%
31 December 2023
Summary:
Pharming Group NV annual cash flow from investing activities is currently -$129.39 million, with the most recent change of -$134.71 million (-2530.73%) on 31 December 2023. During the last 3 years, it has fallen by -$113.76 million (-727.87%). PHAR annual CFI is now -2249.16% below its all-time high of $6.02 million, reached on 31 December 2009.PHAR Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$4.35 M
-$32.04 M-88.05%
30 September 2024
Summary:
Pharming Group NV quarterly cash flow from investing activities is currently $4.35 million, with the most recent change of -$32.04 million (-88.05%) on 30 September 2024. Over the past year, it has increased by +$62.58 million (+107.47%). PHAR quarterly CFI is now -88.05% below its all-time high of $36.39 million, reached on 30 June 2024.PHAR Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$37.50 M
+$62.58 M+249.54%
30 September 2024
Summary:
Pharming Group NV TTM cash flow from investing activities is currently $37.50 million, with the most recent change of +$62.58 million (+249.54%) on 30 September 2024. Over the past year, it has increased by +$163.38 million (+129.79%). PHAR TTM CFI is now at all-time high.PHAR TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHAR Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2530.7% | +107.5% | +129.8% |
| 3 y3 years | -727.9% | +158.4% | +298.6% |
| 5 y5 years | -2901.1% | +121.7% | +251.8% |
PHAR Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -2530.7% | at low | -88.0% | +106.5% | at high | +129.0% |
| 5 y | 5 years | -2530.7% | at low | -88.0% | +106.5% | at high | +129.0% |
| alltime | all time | -2249.2% | at low | -88.0% | +106.5% | at high | +129.0% |
Pharming Group NV Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $4.35 M(-88.0%) | $37.50 M(-249.5%) |
| June 2024 | - | $36.39 M(+5381.0%) | -$25.08 M(-80.5%) |
| Mar 2024 | - | $664.00 K(-117.0%) | -$128.51 M(-0.7%) |
| Dec 2023 | -$129.39 M(-2530.7%) | -$3.91 M(-93.3%) | -$129.39 M(+2.8%) |
| Sept 2023 | - | -$58.23 M(-13.1%) | -$125.88 M(+85.3%) |
| June 2023 | - | -$67.04 M(>+9900.0%) | -$67.95 M(-1339.3%) |
| Mar 2023 | - | -$215.00 K(-46.1%) | $5.48 M(+3.0%) |
| Dec 2022 | $5.32 M(-125.0%) | -$399.00 K(+33.9%) | $5.32 M(-1411.1%) |
| Sept 2022 | - | -$298.00 K(-104.7%) | -$406.00 K(-94.6%) |
| June 2022 | - | $6.39 M(-1805.3%) | -$7.56 M(-60.4%) |
| Mar 2022 | - | -$375.00 K(-93.9%) | -$19.11 M(-10.3%) |
| Dec 2021 | -$21.30 M(+36.3%) | -$6.13 M(-17.8%) | -$21.30 M(+12.8%) |
| Sept 2021 | - | -$7.45 M(+44.4%) | -$18.88 M(+45.4%) |
| June 2021 | - | -$5.16 M(+101.2%) | -$12.99 M(+15.3%) |
| Mar 2021 | - | -$2.56 M(-30.8%) | -$11.27 M(-27.9%) |
| Dec 2020 | -$15.63 M(-44.7%) | -$3.71 M(+138.1%) | -$15.63 M(+2.3%) |
| Sept 2020 | - | -$1.56 M(-54.8%) | -$15.28 M(-54.8%) |
| June 2020 | - | -$3.44 M(-50.3%) | -$33.80 M(-2.9%) |
| Mar 2020 | - | -$6.93 M(+106.4%) | -$34.80 M(+23.1%) |
| Dec 2019 | -$28.26 M(+555.4%) | -$3.36 M(-83.3%) | -$28.26 M(+14.4%) |
| Sept 2019 | - | -$20.08 M(+352.7%) | -$24.70 M(+263.0%) |
| June 2019 | - | -$4.44 M(+1051.5%) | -$6.80 M(+87.7%) |
| Mar 2019 | - | -$385.20 K(-292.0%) | -$3.62 M(-15.9%) |
| Dec 2018 | -$4.31 M(-40.6%) | $200.60 K(-109.2%) | -$4.31 M(-30.9%) |
| Sept 2018 | - | -$2.18 M(+73.8%) | -$6.24 M(-13.7%) |
| June 2018 | - | -$1.26 M(+17.1%) | -$7.23 M(-2.7%) |
| Mar 2018 | - | -$1.07 M(-37.8%) | -$7.43 M(+2.5%) |
| Dec 2017 | -$7.25 M(-88.0%) | -$1.73 M(-45.7%) | -$7.25 M(-88.8%) |
| Sept 2017 | - | -$3.18 M(+117.6%) | -$64.94 M(+4.8%) |
| June 2017 | - | -$1.46 M(+63.8%) | -$61.96 M(+1.5%) |
| Mar 2017 | - | -$891.20 K(-98.5%) | -$61.06 M(+1.0%) |
| Dec 2016 | -$60.45 M | -$59.41 M(>+9900.0%) | -$60.45 M(+4662.9%) |
| Sept 2016 | - | -$197.90 K(-64.9%) | -$1.27 M(-6.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2016 | - | -$564.50 K(+107.5%) | -$1.36 M(+14.1%) |
| Mar 2016 | - | -$272.00 K(+15.9%) | -$1.19 M(+21.6%) |
| Dec 2015 | -$981.80 K(+23.5%) | -$234.70 K(-19.6%) | -$981.90 K(+8.1%) |
| Sept 2015 | - | -$291.80 K(-26.3%) | -$908.00 K(-27.4%) |
| June 2015 | - | -$395.80 K(+564.1%) | -$1.25 M(+46.3%) |
| Mar 2015 | - | -$59.60 K(-62.9%) | -$854.90 K(+7.5%) |
| Dec 2014 | -$795.30 K(-339.0%) | -$160.80 K(-74.7%) | -$795.30 K(+26.9%) |
| Sept 2014 | - | -$634.50 K(<-9900.0%) | -$626.90 K(-3348.2%) |
| June 2014 | - | $0.00(0.0%) | $19.30 K(-814.8%) |
| Mar 2014 | - | $0.00(-100.0%) | -$2700.00(-100.8%) |
| Dec 2013 | $332.80 K(+133.1%) | $7600.00(-35.0%) | $332.80 K(+1.4%) |
| Sept 2013 | - | $11.70 K(-153.2%) | $328.10 K(-72.3%) |
| June 2013 | - | -$22.00 K(-106.6%) | $1.18 M(+84.9%) |
| Mar 2013 | - | $335.50 K(>+9900.0%) | $639.70 K(+348.0%) |
| Dec 2012 | $142.80 K(-110.0%) | $2900.00(-99.7%) | $142.80 K(-135.7%) |
| Sept 2012 | - | $866.60 K(-253.3%) | -$400.40 K(-68.9%) |
| June 2012 | - | -$565.30 K(+250.2%) | -$1.29 M(-3.7%) |
| Mar 2012 | - | -$161.40 K(-70.1%) | -$1.34 M(-6.0%) |
| Dec 2011 | -$1.42 M(+17.7%) | -$540.30 K(+2424.8%) | -$1.42 M(+22.2%) |
| Sept 2011 | - | -$21.40 K(-96.5%) | -$1.17 M(-42.6%) |
| June 2011 | - | -$614.30 K(+148.6%) | -$2.03 M(+42.6%) |
| Mar 2011 | - | -$247.10 K(-12.4%) | -$1.42 M(+17.7%) |
| Dec 2010 | -$1.21 M(-120.1%) | -$282.20 K(-68.1%) | -$1.21 M(-121.8%) |
| Sept 2010 | - | -$885.30 K(>+9900.0%) | $5.55 M(-12.5%) |
| June 2010 | - | -$7900.00(-76.5%) | $6.34 M(+4.2%) |
| Mar 2010 | - | -$33.60 K(-100.5%) | $6.09 M(+1.1%) |
| Dec 2009 | $6.02 M(-631.3%) | $6.48 M(-6919.7%) | $6.02 M(-1413.6%) |
| Sept 2009 | - | -$95.00 K(-63.8%) | -$458.30 K(+26.1%) |
| June 2009 | - | -$262.50 K(+160.4%) | -$363.30 K(+260.4%) |
| Mar 2009 | - | -$100.80 K | -$100.80 K |
| Dec 2008 | -$1.13 M(+15.8%) | - | - |
| Dec 2007 | -$978.30 K(-76.8%) | - | - |
| Dec 2006 | -$4.22 M(+23.0%) | - | - |
| Dec 2005 | -$3.43 M | - | - |
FAQ
- What is Pharming Group NV annual cash flow from investing activities?
- What is the all time high annual CFI for Pharming Group NV?
- What is Pharming Group NV annual CFI year-on-year change?
- What is Pharming Group NV quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Pharming Group NV?
- What is Pharming Group NV quarterly CFI year-on-year change?
- What is Pharming Group NV TTM cash flow from investing activities?
- What is the all time high TTM CFI for Pharming Group NV?
- What is Pharming Group NV TTM CFI year-on-year change?
What is Pharming Group NV annual cash flow from investing activities?
The current annual CFI of PHAR is -$129.39 M
What is the all time high annual CFI for Pharming Group NV?
Pharming Group NV all-time high annual cash flow from investing activities is $6.02 M
What is Pharming Group NV annual CFI year-on-year change?
Over the past year, PHAR annual cash flow from investing activities has changed by -$134.71 M (-2530.73%)
What is Pharming Group NV quarterly cash flow from investing activities?
The current quarterly CFI of PHAR is $4.35 M
What is the all time high quarterly CFI for Pharming Group NV?
Pharming Group NV all-time high quarterly cash flow from investing activities is $36.39 M
What is Pharming Group NV quarterly CFI year-on-year change?
Over the past year, PHAR quarterly cash flow from investing activities has changed by +$62.58 M (+107.47%)
What is Pharming Group NV TTM cash flow from investing activities?
The current TTM CFI of PHAR is $37.50 M
What is the all time high TTM CFI for Pharming Group NV?
Pharming Group NV all-time high TTM cash flow from investing activities is $37.50 M
What is Pharming Group NV TTM CFI year-on-year change?
Over the past year, PHAR TTM cash flow from investing activities has changed by +$163.38 M (+129.79%)